CPC C12N 5/062 (2013.01) [C12N 5/0606 (2013.01); C12N 5/0607 (2013.01); C12N 2501/115 (2013.01); C12N 2501/15 (2013.01); C12N 2501/155 (2013.01); C12N 2501/415 (2013.01); C12N 2506/02 (2013.01); C12N 2533/52 (2013.01); C12N 2533/90 (2013.01)] | 20 Claims |
1. A method of obtaining a three-dimensional composition comprising human inner ear sensory tissue, the method comprising the steps of:
(a) culturing human pluripotent stem cell aggregates in a culture medium comprising Fibroblast Growth Factor-2 (FGF-2), a Bone Morphogenetic Protein (BMP), and a small molecule inhibitor of Transforming Growth Factor Beta (TGFB)-mediated signaling for four days;
(b) further culturing the cultured aggregates of (a) in the presence of a Fibroblast Growth Factor (FGF) and an inhibitor of BMP signaling for four days;
(c) contacting the further cultured aggregates of (b) to a Wnt agonist for four days, whereby cells within the contacted aggregates differentiate into pre-otic epithelial cells;
(d) embedding the pre-otic epithelial cells obtained in step (c) in droplets of a semi-solid medium comprising extracellular matrix;
(e) culturing the droplets of embedded pre-otic epithelial cells in a static culture in the presence of a Wnt agonist for 6 days under conditions that promote self-assembly of embedded pre-otic epithelial cells into otic vesicles; and
(f) culturing the droplets of embedded pre-otic epithelial cells of (e) further in a stirring culture for at least 22-42 days, whereby a three-dimensional composition comprising human inner ear sensory tissue is obtained.
|